Thermo Fisher Scientific to Present at the Barclays Global Healthcare Conference on March 14, 2017

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017, at 10:15 a.m. (EDT) at the Loews Miami Hotel, Miami, Fla. You can access the live webcast of... Read more

Thermo Fisher Joins Global ICE MEMORY Initiative

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has joined the ICE MEMORY initiative, a global effort led by the Fondation Université Grenoble Alpes with patronage from the French and Italian National Commissions for United Nations Educational, Scientific, and Cultural Organization (UNESCO) created to protect the memory of... Read more

Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult “Ground-state” Stem Cell Technology

MINNEAPOLIS, Minnesota (March 7, 2017)- Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field intended for cloning, propagating, and differentiating adult “ground-state” stem cells from healthy and diseased epithelial tissues. Working together, Bio-Techne and MCT will transition this breakthrough technology into... Read more

908 Devices’ Commercialization of Oak Ridge National Laboratory Technology Honored with Federal Laboratory Consortium Award

03.06.17 Life Sciences, Applied Markets, Safety & Security 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced that its efforts to develop, build and launch commercial products based on technology licensed from Oak Ridge National Laboratory (ORNL) have been honored by the Federal Laboratory Consortium for Technology Transfer as an... Read more